| Victoria Mings, MS, CCC-SLP | |
|
3049 Ualena St Ste 411, Honolulu, HI 96819-1946 | |
| (601) 641-9594 | |
| (855) 221-4467 |
| Full Name | Victoria Mings |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3049 Ualena St Ste 411, Honolulu, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336855774 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP-2201 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Victoria Mings, MS, CCC-SLP 3049 Ualena St Ste 411, Honolulu, HI 96819-1946 Ph: (601) 641-9594 | Victoria Mings, MS, CCC-SLP 3049 Ualena St Ste 411, Honolulu, HI 96819-1946 Ph: (601) 641-9594 |
News Archive
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Zelboraf (vemurafenib) for the treatment of BRAF V600E mutation-positive, inoperable or metastatic melanoma, as determined by an FDA-approved test.
The coronavirus disease (COVID-19) global pandemic has rapidly spread across the globe, now affecting 180 countries and territories. The United States is the front runner with the highest number of confirmed cases, surpassing both China, Italy, and Spain in the case toll. With the vast spread of the novel coronavirus, scientists and health experts are opting for varied treatments in the hope of helping ailing patients infected with COVID-19.
"The Global Fund to Fight AIDS, Tuberculosis and Malaria will transfer management of a $28.77 million HIV/AIDS grant from Mali's national AIDS council, the Haut Conseil de Lutte contre le Sida (the High Council for the Fight Against AIDS, or HCLNS), to a new principal recipient at the end of the year" after mismanagement of funds was discovered in the country, a Global Fund press release reports.
New healthcare performance results released by the Integrated Healthcare Association (IHA) include a comparison of average composite scores across eight California regions in four performance measurement domains: clinical quality, patient experience, information technology-enabled systemness, and coordinated diabetes care.
An observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children, including multisystem inflammatory syndrome in children (MIS-C), and to characterize the immunologic pathways associated with different disease presentations and outcomes. SARS-CoV-2 is the virus that causes COVID-19.
› Verified 5 days ago
Lauren Marie Eudoxie, M.SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 725 Kapiolani Blvd, Honolulu, HI 96813 Phone: 808-596-4650 | |
Jacquelyn Jarachovic, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1519 Queen Emma St, Honolulu, HI 96813 Phone: 808-587-4510 | |
Shauna Ainuu, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 710 Green St, Honolulu, HI 96813 Phone: 808-536-3764 | |
Maria Jordan, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave Rm 127, Honolulu, HI 96816 Phone: 808-733-4940 | |
Tina Thanh Huong Le, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave # 302, Honolulu, HI 96816 Phone: 808-305-9750 Fax: 808-733-9154 | |
Marissa Lyn Cheape, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave Rm 127, Honolulu, HI 96816 Phone: 808-627-7300 | |
Mrs. Christie Eiko Hoota Iraha, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 475 22nd Ave Rm 127, Honolulu, HI 96816 Phone: 808-282-2333 |